Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation

Abstract

By informing timely targeted treatments, rapid whole-genome sequencing can improve the outcomes of seriously ill children with genetic diseases, particularly infants in neonatal and pediatric intensive care units (ICUs). The need for highly qualified professionals to decipher results, however, precludes widespread implementation. We describe a platform for population-scale, provisional diagnosis of genetic diseases with automated phenotyping and interpretation. Genome sequencing was expedited by bead-based genome library preparation directly from blood samples and sequencing of paired 100-nt reads in 15.5 hours. Clinical natural language processing (CNLP) automatically extracted children’s deep phenomes from electronic health records with 80% precision and 93% recall. In 101 children with 105 genetic diseases, a mean of 4.3 CNLP-extracted phenotypic features matched the expected phenotypic features of those diseases, compared with a match of 0.9 phenotypic features used in manual interpretation. We automated provisional diagnosis by combining the ranking of the similarity of a patient’s CNLP phenome with respect to the expected phenotypic features of all genetic diseases, together with the ranking of the pathogenicity of all of the patient’s genomic variants. Automated, retrospective diagnoses concurred well with expert manual interpretation (97% recall and 99% precision in 95 children with 97 genetic diseases). Prospectively, our platform correctly diagnosed three of seven seriously ill ICU infants (100% precision and recall) with a mean time saving of 22:19 hours. In each case, the diagnosis affected treatment. Genome sequencing with automated phenotyping and interpretation in a median of 20:10 hours may increase adoption in ICUs and, thereby, timely implementation of precise treatments.

Lung biopsy in children's interstitial and diffuse lung disease: Does it alter management?

“…Nonetheless, the advent of rapid whole‐genome sequencing with its growing availability and improved ability to accurately diagnose a variety of genetic etiologies, makes this approach a valid noninvasive means to diagnosis and has decreased the need for biopsy 14 . When available, these tests may lead to a diagnosis of chILD without the need for tissue biopsy and should be considered in the diagnostic decision‐making.…”

Translating genomic testing results for pediatric critical care: Opportunities for genetic counselors

“…Rapid GS has been piloted and is being adopted in pediatric and neonatal critical care settings (Clark et al, ; Farnaes et al, ; Petrikin, Willig, Smith, & Kingsmore, ; Priest et al, ; Stavropoulos et al, ). Conditions seen in this setting can be diagnostically complex and often co‐occur with other diseases.…”

“…Advances in sequencing technologies have drastically decreased both cost and processing time. Analysis that previously took months can now occur in a matter of days (Clark et al, 2019;Miller et al, 2015). The potential for rapid and cost-efficient diagnostics is leading many institutions to develop in-house GS clinical services with the expectation of an exponential increase in their use over the next few years (Kapil, Fishler, Euteneuer, & Brunelli, 2019;Willig et al, 2015).…”

In case you missed it: The Prenatal Diagnosis editors bring you the most significant advances of 2019

“…Deep learning is a subcategory of machine learning; it is based on analyses of actual data and has the capacity to continuously improve its performance with additional data and feedback loops. During 2019, papers began to appear that applied this technology to areas of interest to readers of Prenatal Diagnosis , including improving blastocyst selection for transfer, analysis of placental volume, analysis of multi‐omics to predict risk of preterm delivery, and reducing the time for analysis and reporting of newborn genome sequencing data …”

“…As prenatal genome‐wide sequencing gradually becomes incorporated into clinical care, practical lessons can be learned from the emerging approaches being used in intensive care units . In prior paediatric clinical sequencing studies, the mean time from exome sequencing to diagnosis was 16 days.…”